Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07199517 · ClinicalTrials.gov registry record · NA
Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit
A NA study of Tobacco Use and Cigarette Smoking, sponsored by Abramson Cancer Center at Penn Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 472
- Enrollment target
- 1
- Study location
NCT07199517 is a NA study of Tobacco Use and Cigarette Smoking that is actively recruiting participants, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 472 participants, above the 373-participant average among 76 other Tobacco Use trials with a reported enrollment target (27% higher). The trial reports 1 study location across 1 state.
The verdict
NCT07199517, a NA study of Tobacco Use and Cigarette Smoking, is actively recruiting participants, sponsored by Abramson Cancer Center at Penn Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 472 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to investigate harm-reduction sampling in a choice format versus medicinal nicotine sampling on smoking behavior, identify mechanisms of sampling's effects, and explore moderators of these effects among a national sample of people unmotivated to quit smoking. Participants will be randomized 2:1 to choose one of three harm-reduction products (ECIG, IQOS, ONP) versus a medicinal nicotine control condition (nicotine patch + lozenge, NPL), receive a 4-week starter product regimen, and then be followed for 6 months to assess use behavior.
Conditions Studied
Interventions
- OTHER HRP Sampling period
- OTHER NPL Sampling period
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 472 participants |
| Start Date | 2026-01-12 |
| Est. Completion | 2030-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07199517
The ClinicalTrials.gov registry entry for NCT07199517 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 472 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 373-participant average among 76 other Tobacco Use trials with a reported enrollment target (27% higher). The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Tobacco Use appearing as the primary indexed condition, and to 2 interventions - of which HRP Sampling period is the first listed.
NCT07199517 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07199517 about?
NCT07199517 is a clinical study titled "Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit". This study aims to investigate harm-reduction sampling in a choice format versus medicinal nicotine sampling on smoking behavior, identify mechanisms of sampling's effects, and explore moderators of these effects among a national sample of people unmotivated to quit smoking. Participants will be ran...
What is the current status of trial NCT07199517?
This trial is currently recruiting. It is a NA study. The enrollment target is 472 participants. The study started on 2026-01-12. Estimated completion is 2030-07.
What conditions does trial NCT07199517 study?
This clinical trial studies the following conditions: Tobacco Use, Cigarette Smoking, Cigarette Smoking Behavior.
What interventions are being tested in trial NCT07199517?
The interventions under investigation include: HRP Sampling period (OTHER), NPL Sampling period (OTHER).
Who is sponsoring clinical trial NCT07199517?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07199517 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux
RECRUITING · NA
-
Opioids, Low Nicotine Cigarettes, and Chronic Pain
RECRUITING · NA
-
Reach Through Equitable Implementation in Utah
RECRUITING · NA
-
RTMS Targets Neural Circuits for Smoking Cessation
RECRUITING · NA
-
Cigar Legislation and Regulation in Tobacco for the Young (Project CLARITY)
RECRUITING · NA
-
Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.